Your weekly roundup of the latest news from Drug Topics®.
Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.
Moderna has announced positive topline results from a phase 3 pivotal efficacy study of mRNA-1345, the company’s investigational mRNA vaccine targeting respiratory syncytial virus (RSV) in older adults.
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.
Exploring Challenges, Opportunities for Community Pharmacists in Tobacco Cessation
April 24th 2024By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.